{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:46:20Z","timestamp":1733877980983,"version":"3.30.1"},"reference-count":14,"publisher":"Medknow","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Res Pharm Pract"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jrpp.jrpp_18_28","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T05:58:35Z","timestamp":1551333515000},"page":"25","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of venous thromboembolic event prophylaxis in hospitalized cancer patients: A single-centered retrospective study"],"prefix":"10.4103","volume":"8","author":[{"given":"Zahra","family":"Jahangard-Rafsanjani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sholeh","family":"Ebrahimpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/2319-9644.253212-1","first-page":"81","volume-title":"Guidance for the prevention and treatment of cancer-associated venous thromboembolism","author":"Khorana","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"key-10.4103\/2319-9644.253212-2","first-page":"1404","volume-title":"Incidence of venous thromboembolism in patients with cancer \u2013 A cohort study using linked United Kingdom databases","author":"Walker","year":"2013","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/2319-9644.253212-3","first-page":"1712","volume-title":"Epidemiology of cancer-associated venous thrombosis","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"key-10.4103\/2319-9644.253212-4","first-page":"947","volume-title":"Hospitalisation for venous thromboembolism in cancer patients and the general population: A population-based cohort study in Denmark, 1997-2006","author":"Cronin-Fenton","year":"2010","journal-title":"Br J Cancer"},{"key":"key-10.4103\/2319-9644.253212-5","first-page":"e000188","volume-title":"Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: Review of the literature on current practice and emerging options","author":"Ay","year":"2017","journal-title":"ESMO Open"},{"key":"key-10.4103\/2319-9644.253212-6","first-page":"381","volume-title":"Venous thrombosis in cancer patients: Insights from the FRONTLINE survey","author":"Kakkar","year":"2003","journal-title":"Oncologist"},{"key":"key-10.4103\/2319-9644.253212-7","first-page":"1361","volume-title":"The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: Strategies for improving VTE prophylaxis in hospitalized cancer patients","author":"Khorana","year":"2007","journal-title":"Oncologist"},{"key":"key-10.4103\/2319-9644.253212-8","first-page":"654","volume-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014","author":"Lyman","year":"2015","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2319-9644.253212-9","first-page":"56","volume-title":"International Clinical Practice Guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","author":"Farge","year":"2013","journal-title":"J Thromb Haemost"},{"key":"key-10.4103\/2319-9644.253212-10","first-page":"131","volume-title":"Post-discharge venous thromboembolism after cancer surgery: Extending the case for extended prophylaxis","author":"Merkow","year":"2011","journal-title":"Ann Surg"},{"key":"key-10.4103\/2319-9644.253212-11","first-page":"571","volume-title":"Use of deep vein thrombosis prophylaxis in hospitalized cancer patients","author":"Awar","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"key-10.4103\/2319-9644.253212-12","first-page":"594","volume-title":"Is deep vein thrombosis prophylaxis appropriate in the medical wards.A clinical pharmacists' intervention study?","author":"Khalili","year":"2010","journal-title":"Pharm World Sci"},{"key":"key-10.4103\/2319-9644.253212-13","first-page":"e8497","volume-title":"Deep vein thrombosis prophylaxis evaluation in intensive care unit","author":"Nekoonam","year":"2016","journal-title":"Arch Crit Care Med"},{"key":"key-10.4103\/2319-9644.253212-14","first-page":"4902","volume-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","author":"Khorana","year":"2008","journal-title":"Blood"}],"container-title":["Journal of Research in Pharmacy Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T05:59:45Z","timestamp":1551333585000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrpp.net\/text.asp?2019\/8\/1\/25\/253212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["253212"],"URL":"https:\/\/doi.org\/10.4103\/jrpp.jrpp_18_28","relation":{},"ISSN":["2319-9644"],"issn-type":[{"type":"print","value":"2319-9644"}],"subject":[],"published":{"date-parts":[[2019]]}}}